Gilteritinib is a FLT3 inhibitor, made specifically to treat AML that hasn’t responded to other treatments and has FLT3 mutations. It works by blocking FLT3 kinase, which makes leukemia cells grow. You get Gilteritinib in 40 mg tablets.
You’re supposed to take 120 mg every day, with the pill. One bottle has 90 tablets, which should last you a full month if you take it like they tell you to. This med goes after a specific genetic change, FLT3, which a lot of AML patients have.
It’s like a bullseye for the disease. Gilteritinib is a big deal in the fight against AML, giving hope to folks whose disease just keeps coming back after other stuff doesn’t work.
Reviews
There are no reviews yet.